| Mr Christopher Douglas Brickey, RPH | |
|
4268 Legacy Dr, Frisco, TX 75034-0812 | |
| (214) 705-0362 | |
| (214) 705-0363 |
| Full Name | Mr Christopher Douglas Brickey |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4268 Legacy Dr, Frisco, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033619713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 31579 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher Douglas Brickey, RPH 4268 Legacy Dr, Frisco, TX 75034-0812 Ph: (214) 705-0362 | Mr Christopher Douglas Brickey, RPH 4268 Legacy Dr, Frisco, TX 75034-0812 Ph: (214) 705-0362 |
News Archive
Angelina Jolie received widespread media attention in 2013 when she told the public that she'd tested positive for BRCA1, a gene associated with an increased risk of breast and ovarian cancers, and subsequently had a double mastectomy. Now research shows that this publicity did influence some women's intentions to seek out similar genetic testing.
The trillions of bacteria in the human gut affect our health in multiple ways including effects on immune functions and metabolism.
Pinpointing the prevalence and cost of type 2 diabetes and now, the prevalence of obesity (Body Mass Index [BMI] of 30 or greater), is just a mouse click away thanks to a Web-based tool developed by the National Minority Quality Forum (NMQF).
A drug already used to shrink benign, enlarged prostates could also help to reduce the risk of developing prostate cancer, according to researchers in the US.
AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
› Verified 6 days ago
Terrence Crooks, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3137 White Spruce Dr, Frisco, TX 75033 Phone: 678-464-8229 | |
Jessica Abel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5775 Fm 423, Frisco, TX 75034 Phone: 214-469-1486 | |
Clay Lewis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11999 Dallas Pkwy, Frisco, TX 75033 Phone: 214-872-1515 | |
Hsiaoying Cho, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10530 John W Elliott Dr, Frisco, TX 75033 Phone: 800-424-9002 | |
Payal Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7220 Calypso Ln, Frisco, TX 75036 Phone: 469-527-5497 | |
Shelena Hall, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3205 Main St, Frisco, TX 75034 Phone: 972-731-0615 |